Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction/Experiment 1

From BugSigDB


Needs review

Curated date: 2024/11/04

Curator: Rahila

Revision editor(s): Rahila

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Meibum , Skin of eyelid , Conjunctiva Tarsal gland secretion,Meibum,meibum,Blepharon zone of skin,Eyelid skin,Eyelid zone of skin,Zone of skin of blepharon,Zone of skin of eyelid,Skin of eyelid,skin of eyelid,Conjunctiva,conjunctiva,Conjunctivae,Conjunctivas,Tunica conjunctiva,Wall of conjunctival sac
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Meibomian cyst chalazia,Chalazion,chalazion,cyst, Meibomian,Meibomian cyst,meibomian gland lipogranuloma,meibomian cyst
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control (HCs)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Meibomian gland dysfunction (MGD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients diagnosed with MGD Meibomian gland dysfunction (MGD)
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
61
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Antibiotic usage within 6 months.

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2024/11/05

Curator: Rahila

Revision editor(s): Rahila

Source: Supplementary Figure S2D

Description: Pathogens with differential incidences in meibum between MGD patients and healthy controls (p<0.05)

Abundance in Group 1: increased abundance in Meibomian gland dysfunction (MGD)

NCBI Quality ControlLinks
Pseudomonas fluorescens
Malassezia globosa
Campylobacter coli
Pseudomonas protegens
Campylobacter jejuni
Enterococcus faecium
Pseudomonas aeruginosa
Escherichia coli
Ralstonia pickettii
Pseudomonas mosselii
Enterobacter cloacae complex
Stenotrophomonas maltophilia
Comamonas testosteroni
Serratia marcescens
Bacillus licheniformis
Neisseria sicca
Yarrowia lipolytica
Neisseria meningitidis
Roseomonas gilardii
Staphylococcus capitis

Revision editor(s): Rahila